Search

M2 PRESSWIRE-December 17, 2024-: Graft-Versus-Host Disease Market on Track for Major Expansion by 2034, According to DelveInsight | CSL Behring, Equillium, Biocon, MaaT Pharma, Regimmune, Jazz Pharma, Pharmacyclics, Novartis (C)1994-2024 [...]

T-cell malignancies account for about 10-15% of all lymphoid malignancies, and their treatment often involves chemotherapy, immunotherapy, or stem cell transplantation. These cancers can be particularly challenging due to their [...]

M2 PRESSWIRE-December 11, 2024-: Hypoxic Ischemic Encephalopathy Market Growth to Accelerate in Forecast Period (2024-2034), DelveInsight Analyzes | Takeda Pharma, Bayer AG, Novartis AG, Biogen, AstraZeneca, Eisai Co. Ltd., J&J [...]

M2 PRESSWIRE-December 11, 2024-: Chronic Heart Failure Therapeutics Market Size in the 7MM was ~ USD 8,000 Million in 2023, is expected to grow by 2034 | DelveInsight (C)1994-2024 M2 [...]

M2 PRESSWIRE-December 10, 2024-: Cystic Fibrosis Market on Track for Major Expansion by 2034, According to DelveInsight | Insmed, AstraZeneca, Zambion, The Marcus Foundation, Chiesi Farmaceutici, SolAeroMed (C)1994-2024 M2 COMMUNICATIONS [...]

M2 PRESSWIRE-December 10, 2024-: Cryopyrin-associated Periodic Syndromes Market on Track for Major Expansion by 2034, According to DelveInsight | Amgen, Biovitrum, Novartis, Ventyx Biosciences (C)1994-2024 M2 COMMUNICATIONS RDATE:10122024 The Key [...]

M2 PRESSWIRE-December 9, 2024-: Alcoholic Hepatitis Market Report 2034: Epidemiology Data, Pipeline Therapies, Latest FDA, EMA, PDMA Approvals by DelveInsight | Durect Corporation, Novartis, Intercept Pharmaceuticals, Immuron Ltd. (C)1994-2024 M2 [...]

M2 PRESSWIRE-December 9, 2024-: ANCA-associated Vasculitis Market Expected to Experience Major Growth by 2034, According to DelveInsight | Amgen, GlaxoSmithKline, AstraZeneca, Chemocentryx, Staidson (Beijing) Biopharma, Novartis (C)1994-2024 M2 COMMUNICATIONS RDATE:09122024 [...]

Dublin: Research and Markets has issued the following news release: The 'Sarcoma Drugs - Global Strategic Business Report' report has been added to ResearchAndMarkets.com's offering. The global market for Sarcoma [...]

The lupus nephritis market is poised for growth, driven by rising disease prevalence, advancements in therapeutics such as biologics and targeted therapies, and increased investment in R&D. Heightened awareness and [...]

M2 PRESSWIRE-November 26, 2024-: Osteoarthritis Market expected to rise | Novartis, Ampio Pharmaceuticals, Taiwan Liposome Company, Centrexion Therapeutics, Biosplice Therapeutics, Organogenesis, Kolon Tissuegene, Paradigm (C)1994-2024 M2 COMMUNICATIONS RDATE:26112024 The Osteoarthritis [...]

M2 PRESSWIRE-November 20, 2024-: Multiple Myeloma Market on Track for Major Expansion by 2034, According to DelveInsight | Janssen Pharma, Regeneron Pharma, Johnson & Johnson Innovative Medicine, Bristol Myers Squibb, [...]

M2 PRESSWIRE-November 20, 2024-: Myocardial Infarction Market Expected to Experience Major Growth by 2034, According to DelveInsight | Pfizer, Novartis, AstraZeneca, Recardio, Idorsia Pharma, Eli Lilly and Company, Boehringer (C)1994-2024 [...]

M2 PRESSWIRE-November 20, 2024-: KRAS Inhibitors Market Report 2034: Epidemiology Data, Pipeline Therapies, Latest FDA, EMA, PDMA Approvals by DelveInsight | Novartis, Roche, Genentech, Verastem Oncology, Revolution Medicines (C)1994-2024 M2 [...]

The growing comprehension of the pathogenesis of celiac disease has paved the way for the exploration of alternative treatment strategies. These novel approaches are aimed at addressing the condition at [...]

Systemic Lupus Erythematosus (SLE) is a chronic autoimmune disease characterized by inflammation and tissue damage across multiple organ systems, such as the skin, joints, kidneys, heart, and brain. The incidence [...]

M2 PRESSWIRE-November 19, 2024-: Familial Chylomicronemia Syndrome Market Expected to Experience Major Growth by 2034, According to DelveInsight | Ionis Pharma, Novartis, Akcea Therapeutics, Arrowhead Pharma, Visirna Therapeutics (C)1994-2024 M2 [...]

M2 PRESSWIRE-November 14, 2024-: CAR T-Cell Therapy For Acute Lymphoblastic Leukemia Market on Track for Major Expansion by 2034, According to DelveInsight | Eli Lilly and Company, Gilead Sciences, Novartis, [...]

Dublin: Research and Markets has issued the following news release: The 'Alzheimer's Drugs - A Global Market Overview' report has been added to ResearchAndMarkets.com's offering. The global market for Alzheimer's [...]

M2 PRESSWIRE-October 31, 2024-: Hemophagocytic Lymphohistiocytosis Market to Reach New Heights in Growth by 2034, DelveInsight Predict | Incyte, Novartis, Atara Biotherapeutics, Bellicum Pharma (C)1994-2024 M2 COMMUNICATIONS RDATE:31102024 The Key [...]

M2 PRESSWIRE-October 28, 2024-: 'Top Biotech Opportunities: RVNC, HCTI, GLUE, PRSO, CRDL, Showing Promising Developments' (C)1994-2024 M2 COMMUNICATIONS RDATE:28102024 Investors are eyeing several biotech stocks for a potential rebound as [...]

M2 PRESSWIRE-October 28, 2024-: ANCA-associated Vasculitis Market Expected to Experience Major Growth by 2034, According to DelveInsight | Chemocentryx, Amgen, GlaxoSmithKline, AstraZeneca, Staidson (Beijing) Biopharma, Novartis (C)1994-2024 M2 COMMUNICATIONS RDATE:28102024 [...]

M2 PRESSWIRE-October 23, 2024-: Axial Spondyloarthritis Market on Track for Major Expansion by 2034, According to DelveInsight | UCB Biopharma, Celgene, Novartis, Pfizer, Merck, Inmagene Biopharma, Galapagos NV, Kyowa Kirin [...]

M2 PRESSWIRE-October 17, 2024-: Global Cancer Therapy Market Size to grow at a CAGR of ~9% by 2030, Evaluates DelveInsight (C)1994-2024 M2 COMMUNICATIONS RDATE:17102024 Cancer Therapy Companies working in the [...]

The CDK4/6 inhibitors market is expected to grow significantly in the coming years. This is mainly due to the increasing incidence of HR+/HER2 breast cancer, the type for which CDK4/6 [...]

Dublin: Research and Markets has issued the following news release: The 'Chronic Urticaria: Competitive Landscape' report has been added to ResearchAndMarkets.com's offering. This report provides a data-driven overview of the [...]

M2 PRESSWIRE-October 7, 2024-: Age-related Macular Degeneration (AMD) Drugs Market to Hit $17.37 Billion by 2029 (C)1994-2024 M2 COMMUNICATIONS RDATE:04102024 Companies within the AMD drugs market are researching newer drug [...]

M2 PRESSWIRE-October 4, 2024-: Hypertrophic Cardiomyopathy Market Expected to Experience Major Growth by 2034, According to DelveInsight | Edgewise Therapeutics, Inc., Lexicon Pharmaceuticals, Shandong Suncadia Medicine, Ji Xing (C)1994-2024 M2 [...]

M2 PRESSWIRE-September 27, 2024-: Fanconi Anemia Market Expected to Experience Major Growth by 2034, According to DelveInsight | Novartis, Foresee Pharma, Rocket Pharma, Jasper Therapeutics (C)1994-2024 M2 COMMUNICATIONS RDATE:27092024 The [...]

M2 PRESSWIRE-September 27, 2024-: Pancreatic Cancer Market to Reach New Heights in Growth by 2034, DelveInsight Predicts | Dragonfly Therapeutics, Keymed B, Tango Therapeutics, Atara Biotherapeutics, Keymed Biosciences Co. Ltd [...]

The rising demand for prostate cancer diagnostics is mainly driven by the growing incidence of the disease, heightened awareness and screening initiatives, and ongoing advancements in diagnostic technologies, projected for [...]

M2 PRESSWIRE-September 24, 2024-: Castrate-resistant Prostate Cancer Market to Show Remarkable Growth Trends from 2023 to 2032, Asserts DelveInsight | Pfizer, Astellas Pharma, Bristol-Myers Squibb, Laekna Therapeutics, Novartis (C)1994-2024 M2 [...]

NEW YORK, Sept. 9, 2024 /PRNewswire/ -- Report on how AI is redefining market landscape- The global autoinjectors market size is estimated to grow by USD 303.65 billion from 2024-2028, [...]

M2 PRESSWIRE-September 5, 2024-: Diabetic Kidney Disease Market to Show Remarkable Growth Trends from 2024 to 2034, DelveInsight Reports | Mitsubishi Tanabe Pharma, Novartis, PhytoHealth Corporation, Eli Lilly and Company, [...]

M2 PRESSWIRE-September 4, 2024-: IgA Nephropathy Market to Show Remarkable Growth Trends from 2024 to 2034, DelveInsight Reports | Novartis, Vera Therapeutics, RemeGen Co., Ltd., Anthera Pharma, Chinook Therapeutic, Ionis [...]

The increasing demand for cancer monoclonal antibodies is mainly driven by the rising incidence of cancer, the growing prevalence of risk factors like smoking, radiation exposure, unhealthy lifestyles, and other [...]

The chemotherapy drugs market is expected to experience significant growth due to several factors, including the rising incidence of various cancers and an increase in risk factors associated with cancer [...]

The market for BCMA-targeted therapies is expected to grow significantly in the coming years. This is due to the increasing number of patients who are being diagnosed with cancer, the [...]

Dublin: Research and Markets has issued the following news release: The 'Rare Kidney Diseases Market: Industry Trends and Global Forecasts, Till 2035: Distribution by Target Disease Indications, Type of Molecule, [...]

The market for radioligand therapies is expected to grow significantly in the coming years. This is due to the increasing number of patients who are being diagnosed with cancer, the [...]

M2 PRESSWIRE-July 9, 2024-: Axial Spondyloarthritis (axSpA) Market Forecasted to Surge in Coming Years, 2023-2032 Analysis by DelveInsight | UCB Biopharma, Celgene, Novartis, Pfizer, Merck, Inmagene Biopharma, Galapagos NV (C)1994-2024 [...]

NEW YORK: Technavio has issued the following news release: The global diffuse large B-cell lymphoma (DLBCL) therapeutics market size is estimated to grow by USD 2.24 billion from 2024-2028, according [...]

Dublin: The 'U.S. Inflammatory Bowel Disease Treatment Market Size, Share & Trends Analysis Report by Type, Drug Class, Route Of Administration, Distribution Channel, Region, and Segment Forecasts, 2024-2030' report has [...]

M2 PRESSWIRE-June 14, 2024-: Gene And Cell Therapies In Rare Disorder Market Size in the 7MM was ~USD 2000 Million in 2023, estimated DelveInsight (C)1994-2024 M2 COMMUNICATIONS RDATE:13062024 DelveInsight's 'Cell [...]

M2 PRESSWIRE-June 11, 2024-: KRAS Inhibitors Market Forecast 2034: FDA, EMA and PDMA Approvals, Epidemiology, Therapies, Companies by DelveInsight (C)1994-2024 M2 COMMUNICATIONS RDATE:11062024 KRAS Inhibitor companies are Novartis, Roche, Genentech, [...]

M2 PRESSWIRE-June 10, 2024-: Bone Metastasis Market Forecast 2032: FDA, EMA and PDMA Approvals, Epidemiology, Therapies, Companies by DelveInsight | XGEVA (denosumab), XOFIGO (radium-223 dichloride), Cabozantinib, 9-ING-41, more (C)1994-2024 M2 [...]

M2 PRESSWIRE-June 10, 2024-: Acanthamoeba Keratitis Market Forecast 2032: FDA, EMA and PDMA Approvals, Epidemiology, Therapies, Companies by DelveInsight (C)1994-2024 M2 COMMUNICATIONS RDATE:10062024 Acanthamoeba Keratitis companies are Allergan, Merck Sharp [...]

M2 PRESSWIRE-June 3, 2024-: Aromatase Inhibitors Market to Grow at a decent CAGR during the Study Period (2020-2034) by DelveInsight | ANI Pharmaceuticals, Pfizer, Novartis (C)1994-2024 M2 COMMUNICATIONS RDATE:03062024 The [...]

M2 PRESSWIRE-May 31, 2024-: PD-1 and PD-L1 Inhibitors Market is expected to sour at a decent CAGR by 2020-2034, eatimates DelveInsight | Isunakinra, Dato-DXd, ONC-392, ZYNYZ (retifanlimab), Spartalizumab (PDR001), more [...]